nach oben

International Ophthalmology

Erschienen in:

01.12.2024 | Original Paper

The role of endothelial growth factor and tear levels in diabetic retinopathy in type 2 diabetes

verfasst von: Hassan Hashemi, Hanieh Ahmadi, Zahra Rostami, Abbas Alishahi, Zahra Heidari

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the tear level of VEGF and the quantity of tear film in type 2 diabetic patients.

Methods

Thirty patients with diabetic retinopathy (DR group) and 30 patients with no DR (NDR group), and 30 healthy subjects with age and gender matching were enrolled in this prospective comparative study. The tear samples were collected using the Schirmer strips, and the amount of moisture absorbed by the strips was used to determine the quantitative level of the tear film. The concentration of VEGF in the tear samples was measured using the enzyme-linked immunosorbent assay method. The variables were compared with an independent t-test and covariance analysis.

Results

Mean tear level of VEGF was significantly higher in DR group (235.42 pg/ml) compared to NDR (75.11 pg/ml) and control (58.77 pg/ml) groups (P ≤ 0.001). There was no significant difference in the mean of VEGF between NDR and control patients (P = 1.00). Mean quantitative tear film levels were 7.15%, 9.72%, and 15.11% in DR, NDR, and healthy subjects, respectively (P < 0.05). The pairwise analysis showed significant differences in the level of VEGF between DR and both NDR (P = 0.001) and normal (P = 0.017) groups. However, there was no significant difference observed between NDR and normal eyes (P = 0.743).

Conclusion

The VEGF level in tear was higher in diabetic patients with DR, independent of tear volume. The tear VEGF measurement can be used as a valuable predictor to prevent DR in diabetic patients.

Shukla UV, Tripathy K (2023). Diabetic retinopathy. In: StatPearls. Treasure island (FL): StatPearls publishing; available from: https://www.ncbi.nlm.nih.gov/books/NBK560805/

Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng CY (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580–1591. https://doi.org/10.1016/j.ophtha.2021.04.027CrossRefPubMed

Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376(9735):124–136. https://doi.org/10.1016/s0140-6736(09)62124-3CrossRefPubMed

Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27(4):331–371. https://doi.org/10.1016/j.preteyeres.2008.05.001CrossRefPubMedPubMedCentral

Ang WJ, Zunaina E, Norfadzillah AJ, Raja-Norliza RO, Julieana M, Ab-Hamid SA, Mahaneem M (2019) Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients. PLoS ONE 14(8):e0221481. https://doi.org/10.1371/journal.pone.0221481CrossRefPubMedPubMedCentral

Costagliola C, Romano V, De Tollis M, Aceto F, dell’Omo R, Romano MR, Pedicino C, Semeraro F (2013) TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm 2013:629529. https://doi.org/10.1155/2013/629529CrossRefPubMedPubMedCentral

Wirostko B, Wong TY, Simó R (2008) Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 27(6):608–621. https://doi.org/10.1016/j.preteyeres.2008.09.002CrossRefPubMed

Kaštelan S, Orešković I, Bišćan F, Kaštelan H, Gverović Antunica A (2020) Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb) 30(3):030502. https://doi.org/10.11613/bm.2020.030502CrossRefPubMed

Vujosevic S, Benetti E, Massignan F, Pilotto E, Varano M, Cavarzeran F, Avogaro A, Midena E (2009) Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol 148(1):111–118. https://doi.org/10.1016/j.ajo.2009.02.031CrossRefPubMed

10.

Kumari S, Venkatesh P, Tandon N, Chawla R, Takkar B, Kumar A (2022) Selfie fundus imaging for diabetic retinopathy screening. Eye (Lond) 36(10):1988–1993. https://doi.org/10.1038/s41433-021-01804-7CrossRefPubMed

11.

Maturi RK, Glassman AR, Josic K, Antoszyk AN, Blodi BA, Jampol LM, Marcus DM, Martin DF, Melia M, Salehi-Had H, Stockdale CR, Punjabi OS, Sun JK (2021) Effect of intravitreous anti-vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the protocol w randomized clinical trial. JAMA Ophthalmol 139(7):701–712. https://doi.org/10.1001/jamaophthalmol.2021.0606CrossRefPubMedPubMedCentral

12.

Park KS, Kim SS, Kim JC, Kim HC, Im YS, Ahn CW, Lee HK (2008) Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol 145(3):432–437. https://doi.org/10.1016/j.ajo.2007.11.011CrossRefPubMed

13.

Derakhshan A, Abrishami M, Khajedaluee M, Omidtabrizi A, Moghaddam SG (2019) Comparison between tear film osmolar cocentration and other tear film function parameters in patients with diabetes mellitus. Korean J Ophthalmol 33(4):326–332. https://doi.org/10.3341/kjo.2013.0146CrossRefPubMedPubMedCentral

14.

Jiao X, Lu D, Pei X, Qi D, Huang S, Song Z, Gu J, Li Z (2020) Type 1 diabetes mellitus impairs diurnal oscillations in murine extraorbital lacrimal glands. Ocul Surf 18(3):438–452. https://doi.org/10.1016/j.jtos.2020.04.013CrossRefPubMed

15.

Pontelli RCN, Souza MCO, Fantucci MZ, de Andrade M, Rocha EM (2019) The role of endocrine disruptors in ocular surface diseases. Med Hypotheses 122:157–164. https://doi.org/10.1016/j.mehy.2018.11.009CrossRefPubMed

16.

Johnson ME, Murphy PJ (2004) Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 23(4):449–474. https://doi.org/10.1016/j.preteyeres.2004.04.003CrossRefPubMed

17.

Enríquez-de-Salamanca A, Castellanos E, Stern ME, Fernández I, Carreño E, García-Vázquez C, Herreras JM, Calonge M (2010) Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis 16:862–873PubMedPubMedCentral

18.

Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R (2010) Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 304(6):649–656. https://doi.org/10.1001/jama.2010.1111CrossRefPubMedPubMedCentral

19.

Organization WH (2020) Diagnosis and management of type 2 diabetes (HEARTS-D). World Health Organization, Geneva, Switzerland

20.

Rifai N (2017) Tietz textbook of clinical chemistry and molecular diagnostics. Elsevier, Health Sciences

21.

Ixcamey M, Palma C (2021) Diabetic macular edema. Dis Mon 67(5):101138. https://doi.org/10.1016/j.disamonth.2021.101138CrossRefPubMed

22.

Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC (1998) Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 46(9):1033–1041. https://doi.org/10.1177/002215549804600907CrossRefPubMed

23.

Kasza M, Balogh Z, Biro L, Ujhelyi B, Damjanovich J, Csutak A, Várdai J, Berta A, Nagy V (2015) Vascular endothelial growth factor levels in tears of patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 253(9):1581–1586. https://doi.org/10.1007/s00417-015-3030-2CrossRefPubMed

24.

Wang J-Y, Kwon J-S, Hsu S-M, Chuang H-S (2020) Sensitive tear screening of diabetic retinopathy with dual biomarkers enabled using a rapid electrokinetic patterning platform. Lab Chip 20(2):356–362. https://doi.org/10.1039/C9LC00975BCrossRefPubMed

25.

Pieczyński J, Szulc U, Harazna J, Szulc A, Kiewisz J (2021) Tear fluid collection methods: review of current techniques. Eur J Ophthalmol 31(5):2245–2251. https://doi.org/10.1177/1120672121998922CrossRefPubMed

26.

Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM (2004) Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 122(11):1631–1640. https://doi.org/10.1001/archopht.122.11.1631CrossRefPubMed

27.

Domngang C, Noutchie AL, Chuisseu PD, Simo FN, Galani BT, Mekieje PT, Nzounji FU, Djahmeni EN, Guewo-Fokeng M, Kagmeni G (2020) Level of VEGF-A and interleukin 6 in lacrimal fluid of patients with diabetic retinopathy. Int J Biol Chem Sci 14(3):664–673CrossRef

28.

The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007) Ocul Surf 5 (2):75–92. https://doi.org/10.1016/s1542-0124(12)70081-2

29.

Zhang X, Zhao L, Deng S, Sun X, Wang N (2016) Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol 2016:8201053. https://doi.org/10.1155/2016/8201053CrossRefPubMedPubMedCentral

30.

Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR (2008) Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 8:10. https://doi.org/10.1186/1471-2415-8-10CrossRefPubMedPubMedCentral

31.

Saini JS, Mittal S (1996) Graded corneal sensitivity for screening of diabetic retinopathy. Indian J Ophthalmol 44(4):219–223PubMed

32.

Salami MO, Aribaba OT, Musa KO, Rotimi-Samuel A, Onakoya AO (2020) Relationship between corneal sensitivity and diabetic retinopathy among diabetics attending a Nigerian Teaching Hospital. Int Ophthalmol 40(10):2707–2716. https://doi.org/10.1007/s10792-020-01456-8CrossRefPubMed

33.

Nepp J, Abela C, Polzer I, Derbolav A, Wedrich A (2000) Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca? Cornea 19(4):487–491. https://doi.org/10.1097/00003226-200007000-00017CrossRefPubMed

34.

Błochowiak KJ, Trzybulska D, Olewicz-Gawlik A, Sikora JJ, Nowak-Gabryel M, Kocięcki J, Witmanowski H, Sokalski J (2018) Levels of EGF and VEGF in patients with primary and secondary Sjögren’s syndrome. Adv Clin Exp Med 27(4):455–461. https://doi.org/10.17219/acem/70800CrossRefPubMed

35.

Rentka A, Hársfalvi J, Berta A, Köröskényi K, Szekanecz Z, Szücs G, Szodoray P, Kemény-Beke Á (2015) Vascular endothelial growth factor in tear samples of patients with systemic sclerosis. Mediators Inflamm 2015:573681. https://doi.org/10.1155/2015/573681CrossRefPubMedPubMedCentral

Titel: The role of endothelial growth factor and tear levels in diabetic retinopathy in type 2 diabetes
verfasst von: Hassan Hashemi
Hanieh Ahmadi
Zahra Rostami
Abbas Alishahi
Zahra Heidari
Publikationsdatum: 01.12.2024
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-024-03064-2

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The role of endothelial growth factor and tear levels in diabetic retinopathy in type 2 diabetes

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Determination of progressive endothelial cell loss after posterior chamber phakic intraocular lens implantation

Relative yield of retinal imaging versus clinical exam in following neovascular exudative age related macular degeneration

Evaluation of the relationship between tear meniscus changes and quality of life outcomes after external dacryocystorhinostomy

Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves’ orbitopathy

Automated analysis of choroidal thickness in patients with systemic lupus erithematosus treated with hydroxychloroquine

Effect of direct oral anticoagulants on bleeding during and after cataract surgery

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde